Somnigroup Q2 Sales Miss, but Issues First 2026 Guidance of $2.85-$3.15; Refinances Debt Ahead of Leggett & Platt Close
SGI is trading near its 52-week low of $60.39 (7.6% above the low) on elevated volume (1.9× avg).
Summary
Somnigroup reported Q2 sales below estimates but beat on adjusted EPS and issued its first 2026 guidance of $2.85-$3.15. It also refinanced debt, extending maturities and reducing interest costs, as it prepares to close the Leggett & Platt acquisition.
Key Events · Earnings and Guidance · SGI
-
Q2 Sales Miss, Adjusted EPS Beat
Net sales of $1,823.5M fell 3.0% YoY, missing the $1.88B consensus. Adjusted EPS of $0.58 beat estimates, up 9.4% from $0.53 a year ago.
-
First 2026 Guidance Issued
Somnigroup initiated full-year 2026 adjusted EPS guidance of $2.85 to $3.15, a concrete signal of confidence following the Mattress Firm integration.
-
Debt Refinancing Lowers Costs, Extends Maturities
Post-quarter, the company amended its credit agreement, securing a $1.2B Term A Loan and $510M incremental revolver, extending maturities to 2031. It prepaid $700M of Term B debt, reducing interest expense.
-
Leverage Within Target Range
Leverage ratio of 2.99x (consolidated indebtedness less netted cash to adjusted EBITDA) is within the company's 2.0-3.0x target range, providing financial flexibility.
Analysis · SGI · Manufacturing
Somnigroup's Q2 sales fell 3% to $1.82B, missing the $1.88B consensus, partly due to Mattress Firm store closures. However, adjusted EPS of $0.58 beat estimates, and the company issued its first full-year 2026 adjusted EPS guidance of $2.85 to $3.15 — a concrete signal of confidence following the Mattress Firm integration. The company also amended its credit agreement post-quarter, securing a $1.2B term loan and $510M incremental revolver, extending maturities to 2031 and prepaying $700M of higher-cost Term B debt. Leverage at 2.99x is within the 2.0-3.0x target range. The pending all-stock acquisition of Leggett & Platt, expected to close by end of Q3 2026, remains on track. The guidance and refinancing provide clarity, but the sales miss and ongoing macro pressures keep the score at 8.
At the time of this filing, SGI was trading at $64.95 on NYSE in the Manufacturing sector, with a market capitalization of approximately $13.6B. The 52-week trading range was $60.39 to $98.56. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.